0001437749-15-009010.txt : 20150505
0001437749-15-009010.hdr.sgml : 20150505
20150505173524
ACCESSION NUMBER: 0001437749-15-009010
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150501
FILED AS OF DATE: 20150505
DATE AS OF CHANGE: 20150505
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HYPERION THERAPEUTICS INC
CENTRAL INDEX KEY: 0001386858
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 611512713
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 SIERRA POINT PARKWAY
STREET 2: SUITE 400
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 650-745-7802
MAIL ADDRESS:
STREET 1: 2000 SIERRA POINT PARKWAY
STREET 2: SUITE 400
CITY: BRISBANE
STATE: CA
ZIP: 94005
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nash Christine A
CENTRAL INDEX KEY: 0001554403
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35614
FILM NUMBER: 15834293
MAIL ADDRESS:
STREET 1: C/O HYPERION THERAPEUTICS, INC.
STREET 2: 2000 SIERRA POINT PARKWAY, SUITE 400
CITY: BRISBANE
STATE: CA
ZIP: 94005
4
1
rdgdoc.xml
FORM 4
X0306
4
2015-05-01
0001386858
HYPERION THERAPEUTICS INC
HPTX
0001554403
Nash Christine A
C/O HYPERION THERAPEUTICS, INC.
2000 SIERRA POINT PARKWAY, SUITE 400
BRISBANE
CA
94005
1
SVP & Chief Commercial Officer
Common Stock
2015-05-01
4
M
0
16157
1.28
A
53160
D
Common Stock
2015-05-01
4
M
0
12709
4.08
A
65869
D
Common Stock
2015-05-01
4
M
0
30221
7.31
A
96090
D
Employee Stock Option (right to buy)
1.28
2015-05-01
4
M
0
16157
0
D
2020-04-14
Common Stock
16157
0
D
Employee Stock Option (right to buy)
4.08
2015-05-01
4
M
0
12709
0
D
2021-04-14
Common Stock
12709
0
D
Employee Stock Option (right to buy)
7.31
2015-05-01
4
M
0
30221
0
D
2022-04-15
Common Stock
30221
6881
D
This option was vested and exercisable on date of exercise.
/s/ Sally Brammell, Attorney-in-fact
2015-05-05